SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-24-179108
Filing Date
2024-07-15
Accepted
2024-07-15 17:18:32
Documents
21
Period of Report
2024-07-15
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d819205d8k.htm   iXBRL 8-K 25538
2 EX-99.1 d819205dex991.htm EX-99.1 25799
6 GRAPHIC g819205g0715153002822.jpg GRAPHIC 2996
7 GRAPHIC g819205g0715153003127.jpg GRAPHIC 36624
8 GRAPHIC g819205g0715153003372.jpg GRAPHIC 19881
9 GRAPHIC g819205g0715153003638.jpg GRAPHIC 20159
10 GRAPHIC g819205g0715153003859.jpg GRAPHIC 20605
11 GRAPHIC g819205g0715153004093.jpg GRAPHIC 23473
12 GRAPHIC g819205g0715153004317.jpg GRAPHIC 19226
  Complete submission text file 0001193125-24-179108.txt   375853

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA bntc-20240715.xsd EX-101.SCH 2886
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE bntc-20240715_lab.xml EX-101.LAB 17235
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE bntc-20240715_pre.xml EX-101.PRE 10836
23 EXTRACTED XBRL INSTANCE DOCUMENT d819205d8k_htm.xml XML 3485
Mailing Address 3940 TRUST WAY HAYWARD CA 94545
Business Address 3940 TRUST WAY HAYWARD CA 94545 (510) 780-0819
Benitec Biopharma Inc. (Filer) CIK: 0001808898 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39267 | Film No.: 241118051
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)